Matrix Genomics

New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson’s disease, according to a study released February 17 that will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto April 10 to April 17, 2010.
The research involved 136,474 people who did not have Parkinson’s disease at [...]

Matrix Genomics, Inc. is offering a new test for Parkinson’s disease. It is based on now-published research. This research identified a concise genetic signature found among a third of Parkinson’s disease (PD) patients—but at very low frequency in the general population. The signature is found in the LRRK2 gene located on chromosome 12. The work [...]